ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,408,923, issued on Sept. 9, was assigned to COVIDIEN LP (Mansfield, Mass.).
"Occlusive devices with thrombogenic inserts" was invented by Mehdi Rashidi (Irvine, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Devices for treating vascular defects and associated systems and methods are disclosed herein. In some embodiments, an occlusive device for treating an aneurysm includes an expandable mesh configured to span a neck of the aneurysm. The expandable mesh can include an upper wall and a lower wall. The occlusive device can also include an insert positioned within the expandable mesh between the upper and lower walls. The insert can have an inner...